Menu Search
Equities

Organogenesis Holdings Inc

2PQ:DUS

Organogenesis Holdings Inc

Actions
  • Price (EUR)3.04
  • Today's Change0.08 / 2.70%
  • Shares traded--
  • 1 Year change+62.57%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 15:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Organogenesis Holdings Inc's revenues fell -3.94% from 450.89m to 433.14m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 15.53m to 4.95m, a -68.16% decrease.
Gross margin75.14%
Net profit margin-3.69%
Operating margin-2.44%
Return on assets-3.70%
Return on equity-6.19%
Return on investment-4.51%
More ▼

Cash flow in USDView more

In 2023, Organogenesis Holdings Inc did not generate a significant amount of cash. However, the company earned 30.92m from its operations for a Cash Flow Margin of 7.14%. In addition the company used 24.36m on investing activities and also paid 5.51m in financing cash flows.
Cash flow per share-0.0029
Price/Cash flow per share--
Book value per share1.99
Tangible book value per share1.66
More ▼

Balance sheet in USDView more

Organogenesis Holdings Inc has a Debt to Total Capital ratio of 20.01%, a lower figure than the previous year's 23.55%.
Current ratio2.73
Quick ratio2.42
Total debt/total equity0.2502
Total debt/total capital0.2001
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.